Lilly's Strategy for Emerging Markets Relies on 'Branded Generics'

WuXi Biologics Ireland site gets EMA approval for commercial biologics manufacturing

Oxford Biomedica expands US capacity to meet viral vector demand

ProBio launches cGMP AAV manufacturing at New Jersey facility

Made Scientific opens GMP cell therapy facility in New Jersey